Suman Ethel, D'souza Sushma Janet, Jacob Pyari, Sushruth M R, Kotian M Shashidhar
Department of Microbiology, Kasturba Medical College, Manipal University, Mangalore, India.
Indian J Med Sci. 2011 Sep;65(9):387-92.
Intravascular catheters and urinary catheters are an important source of hospital-acquired infections. Many microorganisms colonize indwelling catheters, including central venous catheters (CVCs) forming biofilms and cause infections that are difficult to treat. Although various methods have been employed to reduce biofilms, enzymes involved in bacterial cell wall synthesis could provide novel targets for the development of anti-biofilm agents. N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU) is an essential enzyme in aminosugars metabolism and catalyzes the formation of uridine-diphospho-N-acetylglucosamine (UDP-GlcNAc), an important precursor in the peptidoglycan and lipopolysaccharide biosynthesis of Gram-positive and Gram-negative bacteria. Previous study has been conducted on the anti-biofilm effect of GlmU inhibitors such as N-ethyl maleimide (NEM) and NEM analogs along with a cationic polypeptide protamine sulfate (PS), which enhanced its anti-biofilm activity.
The present study aimed at finding the effect of sub-inhibitory concentrations of N-ethyl maleimide (NEM) and protamine sulfate (PS) on the biofilms produced by Pseudomonas aeruginosa and Enterococcus spp. isolated from cases of catheter-associated UTI as well as Klebsiella pneumoniae and Staphylococcus aureus isolated from cases of catheter-related bloodstream infections (CRBSI).
In order to enhance the activity of NEM and to develop a broad-spectrum anti-microbial composition, NEM (50 μg/ml) was combined with protamine sulfate (50 μg/ml) and tested for anti-biofilm activity using a standard quantitative biofilm assay method.
It was observed that NEM had no effect on the biofilm produced by Pseudomonas aeruginosa as well as by Enterococcus spp. NEM also caused a significant decrease in biofilm production by Staphylococcus aureus while it had no effect on the biofilm produced by Klebsiella pneumoniae. There was a significant synergistic inhibitory effect on Staphylococcus aureus and Enterococcus spp., whereas Pseudomonas aeruginosa and Klebsiella pneumoniae remained unaffected. Combination of GlmU inhibitor-plus-protamine sulfate failed to significantly reduce bacterial adherence of Pseudomonas aeruginosa and Klebsiella pneumoniae to catheter and cannula pieces, respectively. We found that the GlmU inhibitor was mainly effective in preventing the adherence and biofilm formation by gram-positive organisms. The combination of NEM and protamine sulfate may, therefore, be tried as anti-infective coatings for medical devices such as catheters and cannulas, and thus help in overcoming microbial resistance in the current era of increasing device-associated hospital infections.
血管内导管和导尿管是医院获得性感染的重要来源。许多微生物定植于留置导管,包括形成生物膜的中心静脉导管(CVC),并引发难以治疗的感染。尽管已采用多种方法来减少生物膜,但参与细菌细胞壁合成的酶可为抗生物膜药物的开发提供新靶点。N-乙酰葡糖胺-1-磷酸尿苷转移酶(GlmU)是氨基糖代谢中的一种关键酶,催化尿苷二磷酸-N-乙酰葡糖胺(UDP-GlcNAc)的形成,UDP-GlcNAc是革兰氏阳性菌和革兰氏阴性菌肽聚糖和脂多糖生物合成中的一种重要前体。此前已对GlmU抑制剂如N-乙基马来酰亚胺(NEM)及其类似物以及阳离子多肽硫酸鱼精蛋白(PS)的抗生物膜作用进行了研究,PS可增强其抗生物膜活性。
本研究旨在探讨亚抑制浓度的N-乙基马来酰亚胺(NEM)和硫酸鱼精蛋白(PS)对从导管相关尿路感染病例中分离出的铜绿假单胞菌和肠球菌属,以及从导管相关血流感染(CRBSI)病例中分离出的肺炎克雷伯菌和金黄色葡萄球菌所产生生物膜的影响。
为增强NEM的活性并开发一种广谱抗菌组合物,将NEM(50μg/ml)与硫酸鱼精蛋白(50μg/ml)联合使用,并采用标准定量生物膜检测方法检测其抗生物膜活性。
观察到NEM对铜绿假单胞菌和肠球菌属所产生的生物膜无影响。NEM还使金黄色葡萄球菌的生物膜生成显著减少,而对肺炎克雷伯菌所产生的生物膜无影响。对金黄色葡萄球菌和肠球菌属有显著的协同抑制作用,而铜绿假单胞菌和肺炎克雷伯菌则不受影响。GlmU抑制剂加硫酸鱼精蛋白的组合未能分别显著降低铜绿假单胞菌和肺炎克雷伯菌对导管和插管片的细菌黏附。我们发现GlmU抑制剂主要有效地防止革兰氏阳性菌的黏附和生物膜形成。因此,NEM和硫酸鱼精蛋白的组合可尝试用作导管和插管等医疗器械的抗感染涂层,从而有助于在当前与器械相关的医院感染不断增加的时代克服微生物耐药性。